Brent Saunders
Brent Saunders (1969 or 1970) is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.
Brent Saunders | |
|---|---|
| Born | February 6, 1970 |
| Alma mater | Bachelor's, University of Pittsburgh MBA, Temple University JD, Temple University |
| Occupation(s) | Chairman and CEO of Bausch + Lomb Founder of Vesper Healthcare Acquisition Chairman of The Beauty Health Company Chairman of Hugel America |
| Known for | Biopharma executive, entrepreneur |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.